Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection-Reference-Cited by-同舟云学术

Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection

Published:2006-08 Issue:4 Volume:36 Page:283-291
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Hornberger John,Torriani Francesca J.,Dieterich Douglas T.,Bräu Norbert,Sulkowski Mark S.,Torres Maribel Rodriguez,Green Jesse,Patel Kavita

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference46 articles.

1. Hepatitis C co-infection increases mortality in HIV-infected veterans treated with highly active antiretroviral therapy (abstract no. 800);Backus,2004

2. Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C;Bennett;Ann Intern Med,1997

3. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection;Bica;Clin Infect Dis,2001

4. Pegylated interferon alfa-2b vs. standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial;Carrat;JAMA,2004

5. Health-state utilities and quality of life in hepatitis C patients;Chong;Am J Gastroenterol,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?;Journal of the International AIDS Society;2018-04

2. Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States;Advances in Therapy;2016-06-24

3. Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection;Alimentary Pharmacology & Therapeutics;2014-07-28

4. Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C;PLoS ONE;2014-03-06

5. Hepatitis C Direct-Acting Antiviral Agents in HIV/HCV Co-infected Patients;Current Treatment Options in Infectious Diseases;2014-02-01